Lexaria Bioscience Corp is a healthcare company. The Company is primarily engaged in developing drug delivery technology, DehydraTECH, which improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. The Company's technology can be applied to many different ingestible product formats, including foods, beverages...